Interventions to Decrease Financial Toxicity (P-COC)
Cancer, Breast, Cancer Colorectal, Cancer, Ovarian
About this trial
This is an interventional supportive care trial for Cancer, Breast focused on measuring financial toxicity, financial distress, costs of care
Eligibility Criteria
Inclusion Criteria: Newly diagnosed ovarian cancer (i.e., stage II-IV epithelial histology receiving surgery and chemotherapy), or newly diagnosed cervical cancer (i.e., locally advanced stage IB3-IVA receiving chemoradiation), or newly diagnosed uterine cancer (i.e., high-risk histology likely to receive chemotherapy; serous/clear cell), or newly diagnosed stage I-III breast cancer (i.e., high-risk histology), or newly diagnosed stage III-IV Colorectal Cancer Receiving systemic therapy or radiation at University of Alabama at Birmingham O'Neal Comprehensive Cancer Center With health insurance coverage With reliable access to a phone, mobile device, or Internet Exclusion Criteria: Unable to read English Does not agree to complete surveys
Sites / Locations
- O'Neal Comprehensive Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Proactive Cost of Care (P-COC) intervention
Usual Care
One time session with trained educator to review: Cost Information Flyer: Anticipated out of pocket costs flyer by cancer type and stage Cost Tracking workbook: Out-of-pocket cost tracker Participants also review a "Insurance, Employment, and Financial Assistance flyer" Participants will be reminded to track their costs once a month through an automated text message or e-mail based on patient preference. Participants also receive an existing patient pamphlet "Patient and Family Guide"
Participants receive an existing patient pamphlet "Patient and Family Guide"